Compliance Sourcing:Navigating GRAS and Novel Food Status for Natural Astaxanthin in the US & EU
GRAS Astaxanthin,Novel Food status EU, FDA regulations dietary supplements, algal ingredient compliance, heavy metals testing, supplier regulatory dossier
文章标题
Compliance Sourcing:Navigating GRAS and Novel Food Status for Natural Astaxanthin in the US & EU
详情页描述
Ensure your astaxanthin product has clear market access.This guide details the essential regulatory statuses—GRAS in the US and Novel Food in the EU—that your Natural Astaxanthin supplier must demonstrate, and the documentation required for a smooth product launch.
Facebook收藏标签
#GRAS#NovelFood #FDA #EUCompliance #AlgalIngredients #RegulatoryAffairs #MarketAccess #Astaxanthin #BlueEyesBiotech
文章正文
Introducing a product containing Natural Astaxanthin to the US or European market is a significant commercial opportunity, but one paved with specific regulatory requirements. For procurement managers, the regulatory standing of your raw material supplier is not a secondary concern—it is a primary qualification criterion. The compliance pathway for your finished product is dramatically simplified or complicated by the documentation and approvals your Astaxanthin ingredient supplier possesses.
In the United States, the key regulatory milestone for a novel food ingredient is achieving GRAS (Generally Recognized as Safe) status. Natural Astaxanthin from Haematococcus pluvialis has achieved this through both FDA-reviewed and independent expert panel GRAS determinations. When sourcing, you must verify that your supplier’s specific ingredient is produced in accordance with an existing GRAS conclusion. This provides the legal foundation for its use in dietary supplements and foods, mitigating your brand’s regulatory risk. The supplier should be able to provide a GRAS affidavit or reference the applicable GRAS Notice number.
In the European Union, the pathway is governed by the Novel Food Regulation. Specific preparations of Astaxanthin-rich oil from Haematococcus pluvialis have received Novel Food authorization for use in food supplements. It is imperative to source from a supplier whose product and specifications fall squarely within the scope of an authorized Novel Food entry. The supplier must provide documentation, including the EU authorization reference, that confirms compliance.
Beyond these market-specific approvals, foundational documentation is required: a GMP certificate for dietary supplements, a comprehensive Certificate of Analysis (including heavy metals, microbiological counts, and solvent residues), and allergen statements. Procuring from a supplier with a complete, audit-ready dossier is the most efficient way to ensure your product launch is not delayed by compliance queries.
Blue Eyes Biotech Co., Ltd. provides Natural Astaxanthin that is supported by robust regulatory documentation. We ensure our products align with major market requirements, supplying the necessary GRAS and Novel Food compliance evidence as part of our partnership. We help turn regulatory complexity into a streamlined sourcing advantage. To secure a compliant Astaxanthin supply, contact Blue Eyes Biotech Co., Ltd.: [email protected], www.blueeyes-bio.com, WhatsApp: +66840769830.
